RecruitingNCT06894498

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss


Sponsor

Boston Scientific Corporation

Enrollment

100 participants

Start Date

Mar 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Subject is ≥ 18 years of age at the time of the ESG procedure
  • Subject with a BMI between 30 kg/m2 and 50 kg/m2, inclusive, at the time of the primary ESG procedure using Overstitch Endoscopic Suturing System
  • Subject completed follow-up 1-year from the ESG procedure for weight loss management
  • Subject completed or is eligible for follow-up 5-years from the ESG procedure for weight loss management (visit can be collected either retrospectively or prospectively)
  • Subject has returned for a minimum of one annual follow-up at the treating site for weight loss management annually between two and four years from the procedure.
  • Subject is willing to complete one prospective visit (5 year or 5+ year, as appropriate)
  • Subject is able to read, understand, and sign a written Informed Consent Form to participate in the study

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention: Observational Cohort

No Intervention, Observational Cohort


Locations(8)

Endeavor Health Evanston Hospital

Evanston, Illinois, United States

The University of Texas Health Science Center at Houston

Bellaire, Texas, United States

The BMI Clinic

Double Bay, New South Wales, Australia

CHU de Strasbourg, IHU-Strasbourg

Strasbourg, France

Mohak hi-tech Specialty Hospital

Indore, Madhya Pradesh, India

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, Italy

New You Medical Center

Riyadh, Saudi Arabia

Spire Southampton

Southampton, Hampshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06894498


Related Trials